pharmaceuticals
The lucrative global pharmaceuticals market amply repays the attention shown to its temperature-controlled needs by the air logistics business. US-based IMS Health, a leading provider of intelligence to the sector, estimates that the market was worth US$825 billion in 2010. With a 4 - 7 percent compound annual growth rate predicted through 2013, the global pharmaceutical market value could be more than $975 billion by that time
keeping a constant cold chain pharmaceuticals
D
ata from the Biopharma Cold Chain Sourcebook 2010, published by Pharmaceutical Commerce, puts the value of biopharma logistics services at $43 billion in 2008. Of this, some $5.2 billion, or 12.1 percent, was spent on temperature-
controlled shipping, split between $3.2 billion for logistics and transport, and $2 billion for packaging materials and instrumentation. The pharmaceutical cold-chain market will increase by 10
percent annually between 2008 and 2014, the publication states. Of the 10 top-selling pharmaceutical products worldwide in 2008, five required cold-chain transportation and this number is expected to rise to six of the top 10 in 2011 and seven by 2012. The report added that faster-than-average
growth of biopharma logistics services will come from more trade with emerging countries. While North America and Europe will increase by about 19 percent, Asia is heading for 50 percent, and the rest of the world 33 percent. Growth will also come from
26 AIR LOGISTICS CHINA
a number of vaccination programmes that have expanded significantly through philanthropic efforts such as the Bill and Melinda Gates Foundation, with its $10-billion grant for vaccine development and application over the next decade. However, pharmaceutical companies, freight forwarders and
air carriers must understand and overcome the challenges of cost-effectively delivering high-value, temperature-sensitive pharmaceuticals across widely varying climates to their customers worldwide. The temperature-controlled cold chain in air freight
transportation is a broad and complex subject. Many pharmaceutical products need to be transported or stored in a strictly temperature-controlled environment or they will lose their quality and integrity. Identifying and managing the necessary
data requires, therefore, not only a good grounding in the commercial aspects of pharmaceutical transportation, but also a sound knowledge of the increasing raft of legislation surrounding the supply chain. For many pharmaceutical companies a
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32